-+ 0.00%
-+ 0.00%
-+ 0.00%

Maze Therapeutics President, R&D and CMO Harold Bernstein disposes of USD 445,522 common shares

PUBT·08/14/2026 20:58:00
Listen to the news
Maze Therapeutics President, R&D and CMO Harold Bernstein disposes of USD 445,522 common shares
  • Maze Therapeutics President, R&D and CMO Harold Bernstein sold 16,142 common shares on Aug. 13 at USD 27.61.
  • Sale followed the exercise of stock options for 16,142 shares at USD 10.42.
  • Bernstein’s directly held common stock position fell to zero following the transactions.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Maze Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0002050172-26-000028), on August 14, 2026, and is solely responsible for the information contained therein.